Patents by Inventor Yang Hae Park

Yang Hae Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating alopecia areata acting as a functional antagonist for S1PR1 and S1PR4
    Patent number: 11957665
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating alopecia areata acting as a functional antagonist for S1P receptor's subtypes S1PR1 and S1PR4, and more particularly, relates to a pharmaceutical composition containing as an active ingredient a sphingolipid compound acting as a functional antagonist for S1PR1 and S1PR4, does not cause cardiovascular side effects, and is effective in preventing or treating alopecia areata.
    Type: Grant
    Filed: September 26, 2023
    Date of Patent: April 16, 2024
    Assignee: NEXTGEN BIOSCIENCE CO., LTD.
    Inventors: Bong Yong Lee, Yang Hae Park, Eun Jeong Kim
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE ACTING AS A FUNCTIONAL ANTAGONIST FOR S1PR1 AND S1PR4
    Publication number: 20240041836
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory bowel disease acting as a functional antagonist for S1PR1 and S1PR4 of S1P receptors, and more specifically, to a pharmaceutical composition including, as an active ingredient, a sphingolipid compound which does not cause cardiovascular side effects by acting as a functional antagonist for S1PR1 and S1PR4 and has an effect of preventing or treating inflammatory bowel disease.
    Type: Application
    Filed: September 28, 2023
    Publication date: February 8, 2024
    Applicant: NEXTGEN BIOSCIENCE CO., LTD.
    Inventors: Bong Yong LEE, Yang Hae PARK, Eun Jeong KIM
  • COMPOUND USEFUL FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME AND COMPOSITION INCLUDING SAME
    Publication number: 20140213647
    Abstract: The present invention provides a compound of formula (I) or a prodrug thereof useful for treating or preventing irritable bowel syndrome, and a composition comprising the compound as an active ingredient. Also, the present invention provides a method for treating or preventing irritable bowel syndrome, which comprises administrating a therapeutically or prophylactically effective amount of the compound or the composition to a subject in need of treating or preventing irritable bowel syndrome.
    Type: Application
    Filed: May 16, 2012
    Publication date: July 31, 2014
    Applicant: SK CHEMICALS CO., LTD.
    Inventors: Won suk Sun, Hyo Jin Jeon, Dongsun Min, Woongsik Kim, Taeksu Kim, Do-Seung Kum, Keun-Ho Ryu, Hae-In Rhee, Yang Hae Park, Hyun-Joo Son, Eun-ju Park, Bong-yong Lee, Hojin Namgung, Minseok Park, Minseok Kang
  • COMPOSITION FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME
    Publication number: 20120128807
    Abstract: The present invention relates to a composition or a method for treating or preventing irritable bowel syndrome. The present invention uses Atractylodes japonica rhizome extract, preferably the ethanol water solution extract of Atractylodes japonica rhizome, more preferably the 35-65 v/v % ethanol water solution extract of Atractylodes japonica rhizome for treating or preventing irritable bowel syndrome. Atractylodes japonica rhizome extract shows a surprising effect in suppressing visceral hypersensitivity or improving defecation abnormality caused by stress or bowel irritability.
    Type: Application
    Filed: May 20, 2010
    Publication date: May 24, 2012
    Applicant: SK CHEMICALS CO., LTD.
    Inventors: Won Suck Sun, Taek-Su Kim, Woong Sik Kim, Do-Seung Kum, Keun-Ho Ryu, Hae-In Rhee, Hyo Jin Jeon, Dong Sun Min, Yang Hae Park, Hyun-Joo Son, Eun-Ju Park, Bong-Yong Lee, Hojin Namgung, Minseok Park, Euichaul Oh